Literature DB >> 21320602

Large scale expression and purification of recombinant RNA in Escherichia coli.

Luc Ponchon1, Frédéric Dardel.   

Abstract

Stable, folded RNA are involved in many key cellular processes and can be used as tools for biological, pharmacological and/or molecular design studies. However, their widespread use has been somewhat limited by their fragile nature and by the difficulties associated with their production on a large scale, which were limited to in vitro methods. This work reviews the novel techniques recently developed that allow efficient expression of recombinant RNA in vivo in Escherichia coli. Based on the extensive data available on the genetic and metabolic mechanisms of this model organism, conditions for optimal production can be derived. Combined with a large repertoire of RNA motifs which can be assembled by recombinant DNA techniques, this opens the way to the modular design of RNA molecules with novel properties.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320602     DOI: 10.1016/j.ymeth.2011.02.007

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  15 in total

Review 1.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

2.  New insights for therapeutic recombinant human miRNAs heterologous production: Rhodovolum sulfidophilum vs Escherichia coli.

Authors:  Patrícia Pereira; Augusto Q Pedro; João A Queiroz; Ana R Figueiras; Fani Sousa
Journal:  Bioengineered       Date:  2017-03-10       Impact factor: 3.269

Review 3.  Isotope labeling for studying RNA by solid-state NMR spectroscopy.

Authors:  Alexander Marchanka; Christoph Kreutz; Teresa Carlomagno
Journal:  J Biomol NMR       Date:  2018-04-12       Impact factor: 2.835

4.  Challenges to optimizing RNA nanostructures for large scale production and controlled therapeutic properties.

Authors:  Morgan Chandler; Martin Panigaj; Lewis A Rolband; Kirill A Afonin
Journal:  Nanomedicine (Lond)       Date:  2020-05-26       Impact factor: 5.307

5.  Construction of RNA-Quantum Dot Chimera for Nanoscale Resistive Biomemory Application.

Authors:  Taek Lee; Ajay Kumar Yagati; Fengmei Pi; Ashwani Sharma; Jeong-Woo Choi; Peixuan Guo
Journal:  ACS Nano       Date:  2015-07-13       Impact factor: 15.881

Review 6.  RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.

Authors:  Farzin Haque; Fengmei Pi; Zhengyi Zhao; Shanqing Gu; Haibo Hu; Hang Yu; Peixuan Guo
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-11-03       Impact factor: 9.957

Review 7.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Authors:  Yi Shu; Fengmei Pi; Ashwani Sharma; Mehdi Rajabi; Farzin Haque; Dan Shu; Markos Leggas; B Mark Evers; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

8.  Cholinium-based Good's buffers ionic liquids as remarkable stabilizers and recyclable preservation media for recombinant small RNAs.

Authors:  Augusto Q Pedro; Patrícia Pereira; Maria J Quental; André P Carvalho; Sérgio M Santos; João A Queiroz; Fani Sousa; Mara G Freire
Journal:  ACS Sustain Chem Eng       Date:  2018-11-08       Impact factor: 8.198

9.  Fast production of homogeneous recombinant RNA--towards large-scale production of RNA.

Authors:  Frank H T Nelissen; Elizabeth H P Leunissen; Linda van de Laar; Marco Tessari; Hans A Heus; Sybren S Wijmenga
Journal:  Nucleic Acids Res       Date:  2012-03-28       Impact factor: 16.971

Review 10.  Novel approaches for efficient  in vivo fermentation production of noncoding RNAs.

Authors:  Ai-Ming Yu; Neelu Batra; Mei-Juan Tu; Colleen Sweeney
Journal:  Appl Microbiol Biotechnol       Date:  2020-01-17       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.